DeutschNewstral
Article
Reuters on 2015-03-20 19:37
Report Biogen’s Alzheimer’s drug shows early promise
Related news
- FBiogen’s Alzheimer’s drug shows early promiseft.com
New Alzheimer’s Drug Shows Big Promise in Early TrialThe New York Times
Alzheimer’s drug shows promise in human trialsFOX 8 News Cleveland
FDA approves Biogen’s controversial Alzheimer’s drugNew York Post- BBiogen’s Alzheimer’s Drug Won’t Get Approved, Analyst Saysbarrons.com
Analysts see new hope for approval of Biogen’s Alzheimer’s drugbizjournals.com- Biogen’s controversial Alzheimer’s drug made $1.6M in revenue in JuneNew York Post
- BBiogen’s Alzheimer’s Drug Has Another Shot at Success3 min readbarrons.com
Biogen’s $56 000 Alzheimer’s drug evades Biden’s cost curbspressherald.com
Alzheimer's drug shows promise in early results of studylasvegassun.com
Experimental Drug for Alzheimer’s Patients Shows Promise in Human Trials, Researchers SayKTLA 5- Biogen’s Alzheimer’s drug isn't FDA-approved yet, but it may already have a namebizjournals.com
- BBiogen’s Alzheimer’s Drug Could Be a Winner. One Analyst Recommends the Bet.barrons.com
- MBiogen’s FDA-approved Alzheimer’s drug, first new remedy in almost twenty yearsmvtelegraph.com
- MAlzheimer’s drug Leqembi exhibits promise as injectionmvtelegraph.com